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The interactions between host and microbe can range from a simple teˆte-a`-teˆte to a full-blown
conflagration with multiple layers of mutualism interspersed in between. This Select looks at three
intriguing and yet distinct facets of host-microbe interactions that collectively provide new para-
digms for global health.Lipid nanoparticles can be used to
deliver siRNAs targeting the nucleopro-
tein of Marburg virus. Figure courtesy
of T. Geisbert.Knockdown Delivers a Knockout
Viruses from the Filoviridae family such as Ebola and Marburg that lead to fatal hem-
orrhagic fevers are among the deadliest pathogens known to man. Viral outbreaks
have typically been sporadic and contained; however, the ongoing Ebola outbreak
in West Africa, with its imminent spread to other parts of the continent as well the
world, presents a global challenge in terms of prophylactic and therapeutic options.
A promising collaborative study from Thi et al. (2014) provides a potentially viable
strategy for countering Marburg infections that could well be applied for Ebola in
the near future. Using lipid nanoparticles, the authors deliver siRNAs targeting the
nucleoprotein (NP) of the Marburg Angola strain—possibly the deadliest strain of
this virus—in rhesus macaques. Whereas control animals quickly succumbed to dis-
ease, all 16 animals treated with the NP-siRNAs achieved protection for up to 72 hr.
Remarkably, these siRNAs, designed such that they could potentially be used for
other Marburg strains, were efficacious even 3 days after infection. The delivery ofsiRNAs in mammals has been a challenge, and we have a limited understanding of why some tissues such as the liver actively
take up nanoparticles, whereas others are impenetrable. Further, differences between Ebola and Marburg virus structure
and function would need to be accounted for, although previous work from this group has hinted at the potential efficacy
of using a similar strategy against the RNA polymerase L protein of the Zaire Ebola virus in guinea pigs and nonhuman
primates. Overall, the findings by Thi et al. (2014) strongly move forward a quick and viable therapeutic option for viruses
that are clearly at the forefront of global health challenges.
Thi, E.P., et al. (2014). Sci. Trans. Med. 6, 250ra116.Structural depiction of the highly variable
head and conserved stem regions of
influenza virus HA. Figure courtesy of
A. Ellebedy.It’s All in the Head
Influenza affects millions worldwide and is responsible for several thousand deaths
every year. Seasonal vaccines designed on the basis of viral hemagglutinin (HA)
head regions are helpful in achieving long-term humoral responses; however, the
highly mutagenic nature of viral HA means that vaccines need to be annually
updated to keep up with viral evolution. Now, Ellebedy et al. (2014) propose a
vaccination strategy that induces broadly neutralizing antibody responses against
influenza virus. These antibodies are directed against the stem region of HA,
which, in contrast to the head region, is largely conserved across different
influenza strains. While low levels of HA stem-specific antibodies and memory
B cells could be detected in humans, these responses were minimally boosted
by the seasonal influenza vaccine. In contrast, vaccination of humans with HA
derived from the avian H5N1 virus, a strain that is rarely seen by humans, elicited
a robust antibody response against the stem region. This was due to the absence
of memory B cells to the highly diverse head region of the avian HA molecule,
thereby favoring the engagement of HA stem-specific cross-reactive memory
B cells. This point was further illustrated by the observation that, upon secondary H5N1 vaccination 6 months later,
antibody responses were dominated by those directed against the H5 head region. Overall, these results show that
repeated immunization with identical or very similar HA molecules enforces HA head-specific responses. It also demon-
strates that immunization with HA molecules with novel head epitopes, relative to contemporary influenza strains, is a
potential vaccination strategy to target cross-reactive stem-specific memory B cells and to induce broadly neutralizing
antibody responses.
Ellebedy, A.H., et al. (2014). Proc. Natl. Acad. Sci. USA. Published online August 25, 2014. http://dx.doi.org/10.1073/pnas.
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A commensal bacteria-induced barrier
protective response is required to pre-
vent sensitization to food allergens.
Figure courtesy of C. Nagler.Bugs against Allergy
Food allergies are a growing problem in many parts of the world. The microbiome is
increasingly appreciated to regulate a vast repertoire of physiological processes in the
host. Dysbiosis of the microbiome, often associated with the overuse of antibiotics,
has been linked to disease state and progression in several contexts. The link be-
tween antibiotic usage and allergic responses has been relatively unexplored, and
in this regard, an intriguing study by Stefka et al. (2014) finds that mice that lack gut
microbes or those that have been treated with antibiotics demonstrate increased
allergic responses to dietary antigens. Remarkably, restoration of the microbiome
and, more specifically, colonization with Clostridia, a class of anaerobic spore-form-
ing Firmicutes, prevents sensitization to these food allergens. The authors find that
Clostridia modulate the function of specific subsets of innate lymphoid cells in the
gut to produce IL-22, which regulates intestinal permeability. The results of this study
suggest that a basal function of these abundant mucosa-associated bacteria is to
maintain a conducive immune environment in the gut for limiting antigen uptake inthe blood. Although it remains to be seen which specific Clostridia species mediate this response, given the potentially
life-threatening consequences of anaphylactic shock and the increasing prevalence of food allergies, the findings by Stefka
et al. (2014) may pave the way toward a more simple solution to countering, as well preventing, food allergy.
Stefka, A.T., et al. (2014). Proc. Natl. Acad. Sci. USA. Published online August 25, 2014. http://dx.doi.org/10.1073/pnas.
1412008111.
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